Aberdeen Group plc Grows Stock Position in Equifax, Inc. $EFX

Key Points

• Aberdeen Group plc has increased its stake in Equifax, Inc. by 11.8%, owning approximately 0.08% of the company worth around $25.4 million.
• Equifax's recent earnings report revealed an EPS of $2.00, surpassing estimates, with revenues of $1.54 billion, marking a 7.4% increase compared to last year.
• The company has declared a quarterly dividend of $0.50, representing an annualized yield of 0.9% and a dividend payout ratio of 39.14%.

Aberdeen Group plc raised its holdings in Equifax, Inc. (NYSE:EFX - Free Report) by 11.8% in the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 98,097 shares of the credit services provider's stock after buying an additional 10,365 shares during the quarter. Aberdeen Group plc owned about 0.08% of Equifax worth $25,443,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in EFX. N.E.W. Advisory Services LLC purchased a new stake in Equifax in the first quarter valued at about $28,000. Ameritas Advisory Services LLC purchased a new stake in Equifax in the second quarter valued at about $31,000. Zions Bancorporation National Association UT purchased a new stake in Equifax in the first quarter valued at about $32,000. Adirondack Trust Co. purchased a new stake in Equifax in the second quarter valued at about $59,000. Finally, Exchange Traded Concepts LLC raised its stake in Equifax by 42.4% in the first quarter. Exchange Traded Concepts LLC now owns 272 shares of the credit services provider's stock valued at $66,000 after buying an additional 81 shares during the last quarter. 96.20% of the stock is currently owned by hedge funds and other institutional investors.

Equifax Stock Down 2.2%

Equifax stock opened at $225.20 on Tuesday. The firm has a market cap of $27.88 billion, a price-to-earnings ratio of 44.07, a price-to-earnings-growth ratio of 2.70 and a beta of 1.68. Equifax, Inc. has a 52 week low of $199.98 and a 52 week high of $294.92. The business's 50-day moving average price is $247.29 and its 200 day moving average price is $251.14. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.79.

Equifax (NYSE:EFX - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The credit services provider reported $2.00 EPS for the quarter, topping the consensus estimate of $1.92 by $0.08. The firm had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.51 billion. Equifax had a return on equity of 18.89% and a net margin of 10.95%.Equifax's revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period last year, the company earned $1.82 earnings per share. Equifax has set its Q3 2025 guidance at 1.870-1.970 EPS. FY 2025 guidance at 7.330-7.630 EPS. As a group, sell-side analysts anticipate that Equifax, Inc. will post 7.58 earnings per share for the current year.

Equifax Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 15th. Shareholders of record on Tuesday, September 2nd were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend was Tuesday, September 2nd. Equifax's dividend payout ratio (DPR) is presently 39.14%.

Insider Buying and Selling

In other Equifax news, CEO Mark W. Begor sold 48,264 shares of the firm's stock in a transaction that occurred on Monday, July 28th. The stock was sold at an average price of $241.71, for a total value of $11,665,891.44. Following the sale, the chief executive officer directly owned 142,872 shares of the company's stock, valued at approximately $34,533,591.12. This trade represents a 25.25% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.40% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. Oppenheimer assumed coverage on Equifax in a report on Monday. They issued an "outperform" rating and a $271.00 price objective on the stock. UBS Group increased their price objective on Equifax from $287.00 to $297.00 and gave the company a "buy" rating in a report on Monday, September 15th. JPMorgan Chase & Co. cut their price objective on Equifax from $277.00 to $272.00 and set an "overweight" rating on the stock in a report on Wednesday, July 23rd. Robert W. Baird cut their price objective on Equifax from $310.00 to $289.00 and set an "outperform" rating on the stock in a report on Wednesday, July 23rd. Finally, Citigroup cut their price objective on Equifax from $294.00 to $290.00 and set a "buy" rating on the stock in a report on Wednesday, July 23rd. One investment analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and eight have assigned a Hold rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $281.93.

Equifax Profile

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.